BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S, Chen L. Clinical implications of high NQO1 expression in breast cancers. J Exp Clin Cancer Res. 2014;33:14. [PMID: 24499631 DOI: 10.1186/1756-9966-33-14] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 10.9] [Reference Citation Analysis]
Number Citing Articles
1 Yu H, Gao HY, Guo H, Wang GZ, Yang YQ, Hu Q, Liang LJ, Zhao Q, Xie DW, Rao Y, Zhou GB. Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells. Acta Pharmacol Sin 2021. [PMID: 34035487 DOI: 10.1038/s41401-021-00691-8] [Reference Citation Analysis]
2 Dharmaraja AT. Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria. J Med Chem 2017;60:3221-40. [DOI: 10.1021/acs.jmedchem.6b01243] [Cited by in Crossref: 204] [Cited by in F6Publishing: 165] [Article Influence: 40.8] [Reference Citation Analysis]
3 Kobayashi H, Shigetomi H, Yoshimoto C. Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary. Oncol Lett 2015;10:571-6. [PMID: 26622535 DOI: 10.3892/ol.2015.3268] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhou X, Wang X, Huang Z, Xu L, Zhu W, Liu P. An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer. J Exp Clin Cancer Res 2014;33:94. [PMID: 25373603 DOI: 10.1186/s13046-014-0094-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
5 Chen L, Xie Y, Luo Z, Liu L, Zou Z, Liu H, Kong F, Hao Y, Gao J, Wang L, Ma D, Liu S. Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues. Bioorganic & Medicinal Chemistry Letters 2020;30:127286. [DOI: 10.1016/j.bmcl.2020.127286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Osman NATAG, Abd El-Maqsoud NMR, El Gelany SAA. Correlation of NQO1 and Nrf2 in Female Genital Tract Cancer and Their Precancerous Lesions (Cervix, Endometrium and Ovary). World J Oncol 2015;6:364-74. [PMID: 28983331 DOI: 10.14740/wjon931w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
7 Sun I, Yoon HY, Lim D, Kim K. Recent Trends in In Situ Enzyme-Activatable Prodrugs for Targeted Cancer Therapy. Bioconjugate Chem 2020;31:1012-24. [DOI: 10.1021/acs.bioconjchem.0c00082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Shin WS, Han J, Verwilst P, Kumar R, Kim J, Kim JS. Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy. Bioconjugate Chem 2016;27:1419-26. [DOI: 10.1021/acs.bioconjchem.6b00184] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
9 Mohanta S, Sekhar Khora S, Suresh A. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma. Arch Oral Biol 2019;99:92-106. [PMID: 30641296 DOI: 10.1016/j.archoralbio.2019.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Lin L, Sun J, Tan Y, Li Z, Kong F, Shen Y, Liu C, Chen L. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma. Hum Pathol 2017;69:31-7. [PMID: 28964792 DOI: 10.1016/j.humpath.2017.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
11 Thapa D, Huang SB, Muñoz AR, Yang X, Bedolla RG, Hung CN, Chen CL, Huang TH, Liss MA, Reddick RL, Miyamoto H, Kumar AP, Ghosh R. Attenuation of NAD[P]H:quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGFβ signaling. Commun Biol 2020;3:12. [PMID: 31909204 DOI: 10.1038/s42003-019-0720-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Boroumand M, Pourgholi L, Goodarzynejad H, Ziaee S, Hajhosseini-Talasaz A, Sotoudeh-Anvari M, Mandegary A. NQO1 C609T Polymorphism is Associated with Coronary Artery Disease in a Gender-Dependent Manner. Cardiovasc Toxicol 2017;17:35-41. [PMID: 26690082 DOI: 10.1007/s12012-015-9353-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Selvakumar R, Anantha Krishnan D, Ramakrishnan C, Velmurugan D, Gunasekaran K. Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches. Journal of Biomolecular Structure and Dynamics 2020;38:682-96. [DOI: 10.1080/07391102.2019.1585291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Ino K, Onodera T, Fukuda MT, Nashimoto Y, Shiku H. Combination of Double-Mediator System with Large-Scale Integration-Based Amperometric Devices for Detecting NAD(P)H:quinone Oxidoreductase 1 Activity of Cancer Cell Aggregates. ACS Sens 2019;4:1619-25. [PMID: 30995391 DOI: 10.1021/acssensors.9b00344] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
15 Oh ET, Kim JW, Kim JM, Kim SJ, Lee JS, Hong SS, Goodwin J, Ruthenborg RJ, Jung MG, Lee HJ, Lee CH, Park ES, Kim C, Park HJ. NQO1 inhibits proteasome-mediated degradation of HIF-1α. Nat Commun 2016;7:13593. [PMID: 27966538 DOI: 10.1038/ncomms13593] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 11.5] [Reference Citation Analysis]
16 Guo Y, Xu L, Ling C, Yang T, Zheng W, Lv J, Guo Q, Chen B. Novel β‐carboline‐based indole‐4,7‐quinone derivatives as NAD(P)H: Quinone‐oxidoreductase‐1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage. Chem Biol Drug Des 2020;96:1433-46. [DOI: 10.1111/cbdd.13752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Yang YJ, Dai M, Reo YJ, Song CW, Sarkar S, Ahn KH. NAD(P)H Quinone Oxidoreductase-1 in Organ and Tumor Tissues: Distinct Activity Levels Observed with a Benzo-rosol-Based Dual-Excitation and Dual-Emission Probe. Anal Chem 2021;93:7523-31. [PMID: 33983712 DOI: 10.1021/acs.analchem.1c01178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Luo S, Lei K, Xiang D, Ye K. NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress. Oxid Med Cell Longev 2018;2018:9146528. [PMID: 30595797 DOI: 10.1155/2018/9146528] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
19 Oh ET, Park HJ. Implications of NQO1 in cancer therapy. BMB Rep 2015;48:609-17. [PMID: 26424559 DOI: 10.5483/bmbrep.2015.48.11.190] [Cited by in Crossref: 74] [Cited by in F6Publishing: 37] [Article Influence: 12.3] [Reference Citation Analysis]
20 Šarlauskas J, Pečiukaitytė-alksnė M, Misevičienė L, Marozienė A, Polmickaitė E, Staniulytė Z, Čėnas N, Anusevičius Ž. Naphtho[1′,2′:4,5]imidazo[1,2-a]pyridine-5,6-diones: Synthesis, enzymatic reduction and cytotoxic activity. Bioorganic & Medicinal Chemistry Letters 2016;26:512-7. [DOI: 10.1016/j.bmcl.2015.11.084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
21 Yin J, Yang J, Jiang Z. Discrimination between malignant and benign mass-like lesions from breast dynamic contrast enhanced MRI: semi-automatic vs. manual analysis of the signal time-intensity curves. J Cancer 2018;9:834-40. [PMID: 29581761 DOI: 10.7150/jca.23283] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Zheng Y, Pan D, Zhang Y, Zhang Y, Shen Y. Hemicyanine-based near-infrared fluorescent probe for the ultrasensitive detection of hNQO1 activity and discrimination of human cancer cells. Analytica Chimica Acta 2019;1090:125-32. [DOI: 10.1016/j.aca.2019.09.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
23 Kim DW, Cho JY. NQO1 is Required for β-Lapachone-Mediated Downregulation of Breast-Cancer Stem-Cell Activity. Int J Mol Sci 2018;19:E3813. [PMID: 30513573 DOI: 10.3390/ijms19123813] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
24 Jiang ZN, Ahmed SMU, Wang QC, Shi HF, Tang XW. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival. World J Gastroenterol 2021; 27(22): 3085-3096 [PMID: 34168410 DOI: 10.3748/wjg.v27.i22.3085] [Reference Citation Analysis]
25 Ryan A. Azoreductases in drug metabolism. Br J Pharmacol. 2017;174:2161-2173. [PMID: 27487252 DOI: 10.1111/bph.13571] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
26 Lamberti MJ, Morales Vasconsuelo AB, Chiaramello M, Ferreira VF, Macedo Oliveira M, Baptista Ferreira S, Rivarola VA, Rumie Vittar NB. NQO1 induction mediated by photodynamic therapy synergizes with β-Lapachone-halogenated derivative against melanoma. Biomed Pharmacother 2018;108:1553-64. [PMID: 30372857 DOI: 10.1016/j.biopha.2018.09.159] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
27 Yang Q, Wen Y, Xu J, Shao S. An HBT-based fluorescent dye with enhanced quantum yield in water system and its application for constructing NQO1 fluorescent probe. Talanta 2020;216:120982. [DOI: 10.1016/j.talanta.2020.120982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
28 Parkinson EI, Hergenrother PJ. Deoxynyboquinones as NQO1-Activated Cancer Therapeutics. Acc Chem Res 2015;48:2715-23. [PMID: 26444384 DOI: 10.1021/acs.accounts.5b00365] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
29 Zhang K, Chen D, Ma K, Wu X, Hao H, Jiang S. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer. J Med Chem 2018;61:6983-7003. [DOI: 10.1021/acs.jmedchem.8b00124] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 13.5] [Reference Citation Analysis]
30 Zhong B, Yu J, Hou Y, Ai N, Ge W, Lu JJ, Chen X. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis. Free Radic Biol Med 2021;166:104-15. [PMID: 33600944 DOI: 10.1016/j.freeradbiomed.2021.02.014] [Reference Citation Analysis]
31 Zhou Y, Zhou Y, Yang M, Wang K, Liu Y, Zhang M, Yang Y, Jin C, Wang R, Hu R. Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway. Redox Biol 2019;22:101131. [PMID: 30735911 DOI: 10.1016/j.redox.2019.101131] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
32 Ferraz da Costa DC, Pereira Rangel L, Martins-Dinis MMDDC, Ferretti GDDS, Ferreira VF, Silva JL. Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues. Molecules 2020;25:E893. [PMID: 32085381 DOI: 10.3390/molecules25040893] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
33 Totten SP, Im YK, Cepeda Cañedo E, Najyb O, Nguyen A, Hébert S, Ahn R, Lewis K, Lebeau B, La Selva R, Sabourin V, Martínez C, Savage P, Kuasne H, Avizonis D, Santos Martínez N, Chabot C, Aguilar-Mahecha A, Goulet ML, Dankner M, Witcher M, Petrecca K, Basik M, Pollak M, Topisirovic I, Lin R, Siegel PM, Kleinman CL, Park M, St-Pierre J, Ursini-Siegel J. STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer. Nat Commun 2021;12:3299. [PMID: 34083537 DOI: 10.1038/s41467-021-23396-2] [Reference Citation Analysis]
34 Gerber DE, Beg MS, Fattah F, Frankel AE, Fatunde O, Arriaga Y, Dowell JE, Bisen A, Leff RD, Meek CC, Putnam WC, Kallem RR, Subramaniyan I, Dong Y, Bolluyt J, Sarode V, Luo X, Xie Y, Schwartz B, Boothman DA. Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis. Br J Cancer 2018;119:928-36. [PMID: 30318513 DOI: 10.1038/s41416-018-0278-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
35 Ling Y, Li ZZ, Zhang JF, Zheng XW, Lei ZQ, Chen RY, Feng JH. MicroRNA-494 inhibition alleviates acute lung injury through Nrf2 signaling pathway via NQO1 in sepsis-associated acute respiratory distress syndrome. Life Sci 2018;210:1-8. [PMID: 30121199 DOI: 10.1016/j.lfs.2018.08.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
36 Liang DH, Choi DS, Ensor JE, Kaipparettu BA, Bass BL, Chang JC. The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair. Cancer Lett. 2016;376:249-258. [PMID: 27060208 DOI: 10.1016/j.canlet.2016.04.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 9.8] [Reference Citation Analysis]
37 Liu W, Wu J, Ji X, Ma Y, Liu L, Zong X, Yang H, Dai J, Chen X, Xue W. Advanced biomimetic nanoreactor for specifically killing tumor cells through multi-enzyme cascade. Theranostics 2020;10:6245-60. [PMID: 32483451 DOI: 10.7150/thno.45456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
38 Ankney JA, Xie L, Wrobel JA, Wang L, Chen X. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients. BMC Med Genomics 2019;12:78. [PMID: 31146747 DOI: 10.1186/s12920-019-0530-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
39 Khatoon S, Han HS, Jeon J, Rao NV, Jeong DW, Ikram M, Yasin T, Yi GR, Park JH. Hypoxia-Responsive Mesoporous Nanoparticles for Doxorubicin Delivery. Polymers (Basel) 2018;10:E390. [PMID: 30966424 DOI: 10.3390/polym10040390] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
40 Khunluck T, Kukongviriyapan V, Senggunprai L, Duangarsong W, Prawan A. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells. Integr Cancer Ther 2019;18:1534735418820444. [PMID: 30584780 DOI: 10.1177/1534735418820444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kumari R, Sunil D, Ningthoujam RS. Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review. J Control Release 2020;319:135-56. [PMID: 31881315 DOI: 10.1016/j.jconrel.2019.12.041] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 18.0] [Reference Citation Analysis]
42 Qu Y, Zhang C, Ma X, Gao Y, Liu J, Wu L. Synthesis and biological evaluation of NQO1-activated prodrugs of podophyllotoxin as antitumor agents. Bioorg Med Chem 2020;28:115821. [PMID: 33091789 DOI: 10.1016/j.bmc.2020.115821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Gong Q, Yang F, Hu J, Li T, Wang P, Li X, Zhang X. Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics. Eur J Med Chem 2021;224:113707. [PMID: 34303080 DOI: 10.1016/j.ejmech.2021.113707] [Reference Citation Analysis]
44 Lin LC, Lee HT, Chien PJ, Huang YH, Chang MY, Lee YC, Chang WW. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1. Int J Med Sci 2020;17:2214-24. [PMID: 32922184 DOI: 10.7150/ijms.45706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
45 Klockow JL, Hettie KS, LaGory EL, Moon EJ, Giaccia AJ, Graves EE, Chin FT. An Activatable NIR Fluorescent Rosol for Selectively Imaging Nitroreductase Activity. Sens Actuators B Chem 2020;306:127446. [PMID: 32265579 DOI: 10.1016/j.snb.2019.127446] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
46 Ihling A, Ihling CH, Sinz A, Gekle M. Acidosis-Induced Changes in Proteome Patterns of the Prostate Cancer-Derived Tumor Cell Line AT-1. J Proteome Res 2015;14:3996-4004. [PMID: 26214752 DOI: 10.1021/acs.jproteome.5b00503] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
47 Garufi A, Traversi G, Gilardini Montani MS, D'Orazi V, Pistritto G, Cirone M, D'Orazi G. Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response. Oncotarget 2019;10:4691-702. [PMID: 31384396 DOI: 10.18632/oncotarget.27087] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Shah MA, Rogoff HA. Implications of reactive oxygen species on cancer formation and its treatment. Semin Oncol 2021;48:238-45. [PMID: 34548190 DOI: 10.1053/j.seminoncol.2021.05.002] [Reference Citation Analysis]
49 Shriver CD, Hueman MT, Ellsworth RE. Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes. J Exp Clin Cancer Res 2014;33:116. [PMID: 25551369 DOI: 10.1186/s13046-014-0116-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Xue T, Jia X, Wang J, Xiang J, Wang W, Du J, He Y. “Turn‐On” Activatable AIE Dots for Tumor Hypoxia Imaging. Chem Eur J 2019;25:9634-8. [DOI: 10.1002/chem.201902296] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
51 Lee HY, Parkinson EI, Granchi C, Paterni I, Panigrahy D, Seth P, Minutolo F, Hergenrother PJ. Reactive Oxygen Species Synergize To Potently and Selectively Induce Cancer Cell Death. ACS Chem Biol 2017;12:1416-24. [PMID: 28345875 DOI: 10.1021/acschembio.7b00015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
52 Cui X, Li L, Yan G, Meng K, Lin Z, Nan Y, Jin G, Li C. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. BMC Cancer 2015;15:244. [PMID: 25885439 DOI: 10.1186/s12885-015-1271-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
53 Singh N, Pay SL, Bhandare SB, Arimpur U, Motea EA. Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy. Cancers (Basel) 2020;12:E972. [PMID: 32295316 DOI: 10.3390/cancers12040972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Fiorillo M, Sotgia F, Sisci D, Cappello AR, Lisanti MP. Mitochondrial "power" drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer. Oncotarget 2017;8:20309-27. [PMID: 28411284 DOI: 10.18632/oncotarget.15852] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
55 Tan S, Zhang M, Shi X, Ding K, Zhao Q, Guo Q, Wang H, Wu Z, Kang Y, Zhu T, Sun J, Zhao X. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression. J Exp Clin Cancer Res 2021;40:85. [PMID: 33648552 DOI: 10.1186/s13046-021-01884-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Cheng Z, Valença WO, Dias GG, Scott J, Barth ND, de Moliner F, Souza GBP, Mellanby RJ, Vendrell M, da Silva Júnior EN. Natural product-inspired profluorophores for imaging NQO1 activity in tumour tissues. Bioorg Med Chem 2019;27:3938-46. [PMID: 31327676 DOI: 10.1016/j.bmc.2019.07.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
57 Li WY, Zhou HZ, Chen Y, Cai XF, Tang H, Ren JH, Wai Wong VK, Kwan Law BY, Chen Y, Cheng ST, Yu HB, Cai HY, Chen WX, Tang N, Zhang WL, Tao NN, Yang QX, Ren F, He L, Jiang H, Huang AL, Chen J. NAD(P)H: Quinone oxidoreductase 1 overexpression in hepatocellular carcinoma potentiates apoptosis evasion through regulating stabilization of X-linked inhibitor of apoptosis protein. Cancer Lett 2019;451:156-67. [PMID: 30867140 DOI: 10.1016/j.canlet.2019.02.053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
58 Lee J, Oh E, Yoon H, Woo Kim C, Han Y, Song J, Jang H, Joo Park H, Kim C. Mesoporous nanocarriers with a stimulus-responsive cyclodextrin gatekeeper for targeting tumor hypoxia. Nanoscale 2017;9:6901-9. [DOI: 10.1039/c7nr00808b] [Cited by in Crossref: 30] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
59 Punganuru SR, Madala HR, Arutla V, Srivenugopal KS. Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In Vivo. Cancers (Basel) 2018;10:E470. [PMID: 30487423 DOI: 10.3390/cancers10120470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
60 Shen Z, Prasai B, Nakamura Y, Kobayashi H, Jackson MS, McCarley RL. A Near-Infrared, Wavelength-Shiftable, Turn-on Fluorescent Probe for the Detection and Imaging of Cancer Tumor Cells. ACS Chem Biol 2017;12:1121-32. [PMID: 28240865 DOI: 10.1021/acschembio.6b01094] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
61 Li Z, Zhang Y, Jin T, Men J, Lin Z, Qi P, Piao Y, Yan G. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. BMC Cancer. 2015;15:207. [PMID: 25880877 DOI: 10.1186/s12885-015-1227-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
62 D'Orazi G, Cirone M. Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression. Cancers (Basel) 2019;11:E614. [PMID: 31052524 DOI: 10.3390/cancers11050614] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
63 Moradi Kashkooli F, Soltani M, Souri M. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. J Control Release 2020;327:316-49. [PMID: 32800878 DOI: 10.1016/j.jconrel.2020.08.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
64 Zhu Y, Han J, Zhang Q, Zhao Z, Wang J, Xu X, Hao H, Zhang J. A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living tumor cells. RSC Adv 2019;9:26729-33. [DOI: 10.1039/c9ra05650e] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
65 Akhtari FS, Green AJ, Small GW, Havener TM, House JS, Roell KR, Reif DM, McLeod HL, Wiltshire T, Motsinger-Reif AA. High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs. PLoS Genet 2021;17:e1009732. [PMID: 34437536 DOI: 10.1371/journal.pgen.1009732] [Reference Citation Analysis]
66 Lundberg AP, Francis JM, Pajak M, Parkinson EI, Wycislo KL, Rosol TJ, Brown ME, London CA, Dirikolu L, Hergenrother PJ, Fan TM. Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species. Invest New Drugs 2017;35:134-44. [PMID: 27975234 DOI: 10.1007/s10637-016-0414-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
67 Rajagopal T, Seshachalam A, Rathnam KK, Jothi A, Talluri S, Venkatabalasubramanian S, Dunna NR. Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women. Breast Cancer Res Treat 2021;186:823-37. [PMID: 33392841 DOI: 10.1007/s10549-020-06028-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
68 Tong YH, Zhang B, Yan YY, Fan Y, Yu JW, Kong SS, Zhang D, Fang L, Su D, Lin NM. Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer. Oncotarget 2017;8:45750-8. [PMID: 28501854 DOI: 10.18632/oncotarget.17403] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
69 Wu Z, Wang Q, Yang H, Wang J, Li W, Liu G, Yang Y, Zhao Y, Tang Y. Discovery of Natural Products Targeting NQO1 via an Approach Combining Network-Based Inference and Identification of Privileged Substructures. J Chem Inf Model 2021;61:2486-98. [PMID: 33955748 DOI: 10.1021/acs.jcim.1c00260] [Reference Citation Analysis]
70 Xiao FY, Jiang ZP, Yuan F, Zhou FJ, Kuang W, Zhou G, Chen XP, Liu R, Zhou HH, Zhao XL, Cao S. Down-regulating NQO1 promotes cellular proliferation in K562 cells via elevating DNA synthesis. Life Sci 2020;248:117467. [PMID: 32105706 DOI: 10.1016/j.lfs.2020.117467] [Reference Citation Analysis]
71 Zhang QL, Li XM, Lian DD, Zhu MJ, Yim SH, Lee JH, Jiang RH, Kim CD. Tumor Suppressive Function of NQO1 in Cutaneous Squamous Cell Carcinoma (SCC) Cells. Biomed Res Int 2019;2019:2076579. [PMID: 31886179 DOI: 10.1155/2019/2076579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
72 Liu M, Guo J, Chen B, Xia J, Pu X, Zou X, Yang M, Sizhou Huang. The expression of zebrafish NAD(P)H:quinone oxidoreductase 1(nqo1) in adult organs and embryos. Gene Expr Patterns 2020;38:119134. [PMID: 32889095 DOI: 10.1016/j.gep.2020.119134] [Reference Citation Analysis]
73 Wu L, Ma X, Zhang C, Liu Z. Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents. European Journal of Medicinal Chemistry 2020;198:112396. [DOI: 10.1016/j.ejmech.2020.112396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
74 Liu H, Yao J, Guo H, Cai X, Jiang Y, Lin M, Jiang X, Leung W, Xu C. Tumor Microenvironment-Responsive Nanomaterials as Targeted Delivery Carriers for Photodynamic Anticancer Therapy. Front Chem 2020;8:758. [PMID: 33134254 DOI: 10.3389/fchem.2020.00758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Froeling FEM, Swamynathan MM, Deschênes A, Chio IIC, Brosnan E, Yao MA, Alagesan P, Lucito M, Li J, Chang AY, Trotman LC, Belleau P, Park Y, Rogoff HA, Watson JD, Tuveson DA. Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell Death. Clin Cancer Res 2019;25:7162-74. [PMID: 31527169 DOI: 10.1158/1078-0432.CCR-19-0302] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
76 Madajewski B, Boatman MA, Chakrabarti G, Boothman DA, Bey EA. Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC. Mol Cancer Res 2016;14:14-25. [PMID: 26553038 DOI: 10.1158/1541-7786.MCR-15-0207-T] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
77 Han J, Cheng L, Zhu Y, Xu X, Ge C. Covalent-Assembly Based Fluorescent Probes for Detection of hNQO1 and Imaging in Living Cells. Front Chem 2020;8:756. [PMID: 33005608 DOI: 10.3389/fchem.2020.00756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Walia HK, Singh N, Sharma S. Association of NQO1Pro187Ser polymorphism with clinical outcomes and survival of lung cancer patients treated with platinum chemotherapy. Per Med 2021;18:333-46. [PMID: 33973803 DOI: 10.2217/pme-2020-0119] [Reference Citation Analysis]
79 Dimri M, Humphries A, Laknaur A, Elattar S, Lee TJ, Sharma A, Kolhe R, Satyanarayana A. NAD(P)H Quinone Dehydrogenase 1 Ablation Inhibits Activation of the Phosphoinositide 3-Kinase/Akt Serine/Threonine Kinase and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathways and Blocks Metabolic Adaptation in Hepatocellular Carcinoma. Hepatology 2020;71:549-68. [PMID: 31215069 DOI: 10.1002/hep.30818] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
80 Yang Y, Zhou X, Xu M, Piao J, Zhang Y, Lin Z, Chen L. β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers. Sci Rep 2017;7:2681. [PMID: 28578385 DOI: 10.1038/s41598-017-02937-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
81 Shimokawa M, Yoshizumi T, Itoh S, Iseda N, Sakata K, Yugawa K, Toshima T, Harada N, Ikegami T, Mori M. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma. Cancer Sci 2020;111:1228-40. [PMID: 31968140 DOI: 10.1111/cas.14320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
82 Lee KM, Gwon MR, Lee HW, Seong SJ, Yoon YR. The possibility of low isomerization of β-lapachone in the human body. Transl Clin Pharmacol 2021;29:160-70. [PMID: 34621708 DOI: 10.12793/tcp.2021.29.e16] [Reference Citation Analysis]
83 Wang R, Cai K, Wang H, Yin C, Cheng J. A caged metabolic precursor for DT-diaphorase-responsive cell labeling. Chem Commun (Camb) 2018;54:4878-81. [PMID: 29700507 DOI: 10.1039/c8cc01715h] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Yang Y, Zhu G, Dong B, Piao J, Chen L, Lin Z. The NQO1/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming. Cancer Lett 2019;453:170-83. [PMID: 30954648 DOI: 10.1016/j.canlet.2019.03.054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
85 Kong Q, Deng H, Li C, Wang X, Shimoda Y, Tao S, Kato K, Zhang J, Yamanaka K, An Y. Sustained high expression of NRF2 and its target genes induces dysregulation of cellular proliferation and apoptosis is associated with arsenite-induced malignant transformation of human bronchial epithelial cells. Science of The Total Environment 2021;756:143840. [DOI: 10.1016/j.scitotenv.2020.143840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Yin J, Yang J, Han L, Guo Q, Zhang W. Quantitative discrimination between invasive ductal carcinomas and benign lesions based on semi-automatic analysis of time intensity curves from breast dynamic contrast enhanced MRI. J Exp Clin Cancer Res 2015;34:24. [PMID: 25887917 DOI: 10.1186/s13046-015-0140-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
87 Liu HL, Zong M, Wei H, Lou JJ, Wang SQ, Zou QG, Shi HB, Jiang YN. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps. Clin Radiol 2018;73:460-6. [PMID: 29295753 DOI: 10.1016/j.crad.2017.11.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
88 Punganuru SR, Madala HR, Arutla V, Zhang R, Srivenugopal KS. Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging. Sci Rep 2019;9:8577. [PMID: 31189950 DOI: 10.1038/s41598-019-44111-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]